Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma.
Saved in:
| Title: | Future development of chimeric antigen receptor T cell therapies for patients suffering from malignant glioma. |
|---|---|
| Authors: | Watchmaker PB; Department of Neurosurgery, University of California, San Francisco., Colton M; Department of Neurosurgery, University of California, San Francisco., Pineo-Cavanaugh PL; Department of Neurosurgery, University of California, San Francisco., Okada H; Department of Neurosurgery, University of California, San Francisco.; Parker Institute for Cancer Immunotherapy, San Francisco, California, USA. |
| Source: | Current opinion in oncology [Curr Opin Oncol] 2022 Nov 01; Vol. 34 (6), pp. 661-669. Date of Electronic Publication: 2022 Jul 19. |
| Publication Type: | Journal Article; Review; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Lippincott Williams & Wilkins Country of Publication: United States NLM ID: 9007265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1531-703X (Electronic) Linking ISSN: 10408746 NLM ISO Abbreviation: Curr Opin Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
